The Zephirin Group

The Zephirin Group, Inc. is widely recognized as a World Leading Independent Investment Research Company. The Wall Street Journal, Financial Times/StarMine and FactSet Research have recognized The Zephirin Group as an industry leader – naming us as one of the World's Top Analysts based on high performance and accuracy for earnings and stock picking. The Zephirin Group is a celebrated and award-winning Independent Investment Research Company and has been listed in the Top 5 Star Analyst List for all years 2008 to 2021 YTD. The firm offers equity research, fixed income research, corporate finance, quantitative research, and index research to financial services firms; business research, company profile, and industry studies to business services firms; and data analytics, index analytics, risk analytics, benchmark analytics, financial analysis, model development, and valuation modeling to data services firms. It offers research on small, mid and large capitalized under-valued and under-covered global-listed equities. The firm provides institutional research and sponsored research services. It offers pre-IPO services and reports, boutique services including merger and acquisition advisory, equity and debt raising advisory and energy and real estate advisory services. The firm offers fundamental research with a combination of top down and bottom up research. It also provides consulting on listing issues, compliance, corporate governance, and investor communication services. The Zephirin Group, Inc. is based in New York with satellite office in Hong Kong and Shenzhen.

Lenny Zephirin
  • Lenny Zephirin

ALRPD.PA: Brand value enhance - €1...!

Maintaining Investment Rating. We are reiterating our BUY SPECULATIVE RISK on Rapid Nutrition PLC (ALRPD.PA) and our price objective of €1.00 per share. Plant Based. 2024 is off to a good start as we are seeing the benefits of the acquisition the company did 2 years ago. The Plant-Based Bundle acquisition, which was acquired 2 years ago for approximately $500.0k, is a win-win for the company. The segment generated $976.8k in total revenue in 2023, equating to approximately 59.0% of total reve...

Lenny Zephirin
  • Lenny Zephirin

JDE Peet’s N.V. (JDEP.AS) Momentum pick – BUY…!

Rating Changed. With this brief note, we are adjusting our investment rating to BUY MEDIUM RISK from SELL HIGH RISK on JDE Peet’s N.V. (JDEP.AS), and we are adjusting our price objective to €25 from €22/shr. YTD, the shares are down by approximately 22.0%, and we believe that the shares are attractive at their current level; thus, we recommend accumulating the shares despite the low float of 22.9%. Growing Consumption Rate. Worldwide, JDE Peet’s coffee is consumed at a rate of 4,100-4,500 cup...

Lenny Zephirin
  • Lenny Zephirin

Rapid Nutrition PLC (ALRPD.PA): Recovery is underway…!

Investment Rating and Price Objective. Our investment thesis on Rapid Nutrition PLC (ALRPD.PA – BUY SPECULATIVE), remains unchanged. We continue to believe ALRPD.PA is among the best positioned within our coverage universe given the aggressive re-opening of global markets post-COVID and Generation Z's embrace of wellness and the vegan market, as well as via livestreaming. Inflection Point. 2023 should represent an inflection point as we continue to see a gradual improvement in ongoing strengt...

Lenny Zephirin
  • Lenny Zephirin

Rapid Nutrition PLC (ALRPD.PA):It’s all about September. - PO €1.00/sh...

Investment Rating and Price Objective. Our investment thesis on Rapid Nutrition PLC (ALRPD.PA – BUY SPECULATIVE; PO €1.00/shr.), remains unchanged. We believe the latter part of 2022 will again show strong market movement, with ALRPD.PA as a key beneficiary of a better-than-expected herbal supplemental products recovery. September Bloodbath. The CAC 40 Index has fallen by an average of 1.7% in September since 1991, the worst performance of any month according to our analysis. Nevertheless Apr...

Lenny Zephirin
  • Lenny Zephirin

Rapid Nutrition PLC (ALRPD.PA): The right path – €1.00…!

>Investment Rating and Price Objective. We are reiterating our investment rating BUY SPECULATIVE RISK and our price objective of €1.00 per share. >The Right Path. The company recently announced the intent to acquire a European plant-based brand with operations in the U.S. that should incrementally add to 2H revenues. This acquisition will prove to expand the company’s portfolio of products that align with consumer trends and increase focus on Rapid Nutrition PLC’ brand marketing. Further, this ...

Lenny Zephirin
  • Lenny Zephirin

ALRPD.PA: Brand value enhance - €1...!

Maintaining Investment Rating. We are reiterating our BUY SPECULATIVE RISK on Rapid Nutrition PLC (ALRPD.PA) and our price objective of €1.00 per share. Plant Based. 2024 is off to a good start as we are seeing the benefits of the acquisition the company did 2 years ago. The Plant-Based Bundle acquisition, which was acquired 2 years ago for approximately $500.0k, is a win-win for the company. The segment generated $976.8k in total revenue in 2023, equating to approximately 59.0% of total reve...

Lenny Zephirin
  • Lenny Zephirin

JDE Peet’s N.V. (JDEP.AS) Momentum pick – BUY…!

Rating Changed. With this brief note, we are adjusting our investment rating to BUY MEDIUM RISK from SELL HIGH RISK on JDE Peet’s N.V. (JDEP.AS), and we are adjusting our price objective to €25 from €22/shr. YTD, the shares are down by approximately 22.0%, and we believe that the shares are attractive at their current level; thus, we recommend accumulating the shares despite the low float of 22.9%. Growing Consumption Rate. Worldwide, JDE Peet’s coffee is consumed at a rate of 4,100-4,500 cup...

Lenny Zephirin
  • Lenny Zephirin

Rapid Nutrition PLC (ALRPD.PA): Recovery is underway…!

Investment Rating and Price Objective. Our investment thesis on Rapid Nutrition PLC (ALRPD.PA – BUY SPECULATIVE), remains unchanged. We continue to believe ALRPD.PA is among the best positioned within our coverage universe given the aggressive re-opening of global markets post-COVID and Generation Z's embrace of wellness and the vegan market, as well as via livestreaming. Inflection Point. 2023 should represent an inflection point as we continue to see a gradual improvement in ongoing strengt...

Lenny Zephirin
  • Lenny Zephirin

Rapid Nutrition PLC (ALRPD.PA):It’s all about September. - PO €1.00/sh...

Investment Rating and Price Objective. Our investment thesis on Rapid Nutrition PLC (ALRPD.PA – BUY SPECULATIVE; PO €1.00/shr.), remains unchanged. We believe the latter part of 2022 will again show strong market movement, with ALRPD.PA as a key beneficiary of a better-than-expected herbal supplemental products recovery. September Bloodbath. The CAC 40 Index has fallen by an average of 1.7% in September since 1991, the worst performance of any month according to our analysis. Nevertheless Apr...

Lenny Zephirin
  • Lenny Zephirin

Rapid Nutrition PLC (ALRPD.PA): The right path – €1.00…!

>Investment Rating and Price Objective. We are reiterating our investment rating BUY SPECULATIVE RISK and our price objective of €1.00 per share. >The Right Path. The company recently announced the intent to acquire a European plant-based brand with operations in the U.S. that should incrementally add to 2H revenues. This acquisition will prove to expand the company’s portfolio of products that align with consumer trends and increase focus on Rapid Nutrition PLC’ brand marketing. Further, this ...

Lenny Zephirin
  • Lenny Zephirin

Oil & Gas: OPEC, Market is Wrong...!

Hiccup. While OPEC members have gone through several hiccups the past 43-years, however, total oil production is up by 10.3% from 1974. Ex-Iraq, oil production is up only by 2% from 1974. OPEC market share currently stands at an estimated 36% in July vs. 43% in 2016 and 51% in 1974. OPEC historical low market share was 27.6% in 1985.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch